nodes	percent_of_prediction	percent_of_DWPC	metapath
Droperidol—HTR2A—phrenic nerve—lung cancer	0.111	0.52	CbGeAlD
Droperidol—HTR2A—pulmonary artery—lung cancer	0.0403	0.189	CbGeAlD
Droperidol—Sudden death—Teniposide—lung cancer	0.0263	0.0378	CcSEcCtD
Droperidol—Hypovolaemia—Irinotecan—lung cancer	0.0227	0.0327	CcSEcCtD
Droperidol—Shivering—Gemcitabine—lung cancer	0.0184	0.0265	CcSEcCtD
Droperidol—Inappropriate antidiuretic hormone secretion—Vinblastine—lung cancer	0.0177	0.0254	CcSEcCtD
Droperidol—Ventricular tachycardia—Pemetrexed—lung cancer	0.0166	0.0239	CcSEcCtD
Droperidol—Inappropriate antidiuretic hormone secretion—Vinorelbine—lung cancer	0.0147	0.0211	CcSEcCtD
Droperidol—Sudden death—Irinotecan—lung cancer	0.0138	0.0198	CcSEcCtD
Droperidol—Akathisia—Irinotecan—lung cancer	0.0127	0.0183	CcSEcCtD
Droperidol—Inappropriate antidiuretic hormone secretion—Cisplatin—lung cancer	0.011	0.0158	CcSEcCtD
Droperidol—DRD2—respiratory system—lung cancer	0.0103	0.0481	CbGeAlD
Droperidol—ADRA1A—epithelium—lung cancer	0.00877	0.041	CbGeAlD
Droperidol—Bronchospasm—Teniposide—lung cancer	0.00832	0.0119	CcSEcCtD
Droperidol—Laryngospasm—Etoposide—lung cancer	0.00785	0.0113	CcSEcCtD
Droperidol—Syncope—Crizotinib—lung cancer	0.00714	0.0103	CcSEcCtD
Droperidol—KCNH2—cardiac atrium—lung cancer	0.00703	0.0329	CbGeAlD
Droperidol—Loss of consciousness—Crizotinib—lung cancer	0.007	0.0101	CcSEcCtD
Droperidol—Cardiac arrest—Topotecan—lung cancer	0.0069	0.00991	CcSEcCtD
Droperidol—Sudden death—Methotrexate—lung cancer	0.00686	0.00986	CcSEcCtD
Droperidol—HTR2A—respiratory system—lung cancer	0.00678	0.0317	CbGeAlD
Droperidol—Angioedema—Gefitinib—lung cancer	0.00661	0.00949	CcSEcCtD
Droperidol—Syncope—Pemetrexed—lung cancer	0.00652	0.00937	CcSEcCtD
Droperidol—Loss of consciousness—Pemetrexed—lung cancer	0.00639	0.00918	CcSEcCtD
Droperidol—Shock—Crizotinib—lung cancer	0.00639	0.00918	CcSEcCtD
Droperidol—Hypertension—Pemetrexed—lung cancer	0.00628	0.00902	CcSEcCtD
Droperidol—Chills—Teniposide—lung cancer	0.00607	0.00872	CcSEcCtD
Droperidol—Anaphylactic shock—Pemetrexed—lung cancer	0.00594	0.00853	CcSEcCtD
Droperidol—KCNH2—bone marrow—lung cancer	0.00594	0.0278	CbGeAlD
Droperidol—Shock—Pemetrexed—lung cancer	0.00584	0.00839	CcSEcCtD
Droperidol—Shock—Gefitinib—lung cancer	0.0058	0.00834	CcSEcCtD
Droperidol—Blood pressure increased—Paclitaxel—lung cancer	0.00575	0.00826	CcSEcCtD
Droperidol—Ventricular tachycardia—Paclitaxel—lung cancer	0.00575	0.00826	CcSEcCtD
Droperidol—Depression—Vinblastine—lung cancer	0.00574	0.00824	CcSEcCtD
Droperidol—HTR2A—epithelium—lung cancer	0.00567	0.0265	CbGeAlD
Droperidol—Amenorrhoea—Docetaxel—lung cancer	0.00555	0.00797	CcSEcCtD
Droperidol—Depression—Erlotinib—lung cancer	0.00551	0.00792	CcSEcCtD
Droperidol—Hypotension—Gefitinib—lung cancer	0.00551	0.00792	CcSEcCtD
Droperidol—DRD2—lung—lung cancer	0.00546	0.0256	CbGeAlD
Droperidol—Bronchospasm—Vinorelbine—lung cancer	0.00528	0.00758	CcSEcCtD
Droperidol—Body temperature increased—Crizotinib—lung cancer	0.00514	0.00738	CcSEcCtD
Droperidol—Hypertension—Teniposide—lung cancer	0.00509	0.00731	CcSEcCtD
Droperidol—HTR2A—trachea—lung cancer	0.00501	0.0235	CbGeAlD
Droperidol—Blood pressure increased—Docetaxel—lung cancer	0.00487	0.007	CcSEcCtD
Droperidol—Cardiac arrest—Irinotecan—lung cancer	0.00487	0.00699	CcSEcCtD
Droperidol—Fenbufen—PTGS2—lung cancer	0.0047	0.256	CrCbGaD
Droperidol—Tachycardia—Teniposide—lung cancer	0.00469	0.00674	CcSEcCtD
Droperidol—Body temperature increased—Pemetrexed—lung cancer	0.00469	0.00674	CcSEcCtD
Droperidol—Body temperature increased—Gefitinib—lung cancer	0.00466	0.0067	CcSEcCtD
Droperidol—Chills—Topotecan—lung cancer	0.0045	0.00647	CcSEcCtD
Droperidol—Hypotension—Teniposide—lung cancer	0.00449	0.00646	CcSEcCtD
Droperidol—Chills—Erlotinib—lung cancer	0.00445	0.0064	CcSEcCtD
Droperidol—Hypersensitivity—Pemetrexed—lung cancer	0.00437	0.00628	CcSEcCtD
Droperidol—Hypersensitivity—Gefitinib—lung cancer	0.00435	0.00624	CcSEcCtD
Droperidol—Dizziness—Crizotinib—lung cancer	0.0043	0.00617	CcSEcCtD
Droperidol—Bronchospasm—Gemcitabine—lung cancer	0.00424	0.00609	CcSEcCtD
Droperidol—Ventricular arrhythmia—Doxorubicin—lung cancer	0.00411	0.0059	CcSEcCtD
Droperidol—Rash—Crizotinib—lung cancer	0.0041	0.00588	CcSEcCtD
Droperidol—Dermatitis—Crizotinib—lung cancer	0.00409	0.00588	CcSEcCtD
Droperidol—Cardiac arrest—Etoposide—lung cancer	0.00405	0.00581	CcSEcCtD
Droperidol—Angioedema—Topotecan—lung cancer	0.00399	0.00573	CcSEcCtD
Droperidol—Cardiac arrest—Paclitaxel—lung cancer	0.00397	0.0057	CcSEcCtD
Droperidol—Dizziness—Pemetrexed—lung cancer	0.00393	0.00564	CcSEcCtD
Droperidol—Hyperglycaemia—Gemcitabine—lung cancer	0.00389	0.00558	CcSEcCtD
Droperidol—Hypertension—Vinblastine—lung cancer	0.00388	0.00558	CcSEcCtD
Droperidol—Syncope—Erlotinib—lung cancer	0.00388	0.00557	CcSEcCtD
Droperidol—Pimozide—CYP2E1—lung cancer	0.00387	0.211	CrCbGaD
Droperidol—Body temperature increased—Teniposide—lung cancer	0.0038	0.00546	CcSEcCtD
Droperidol—Loss of consciousness—Erlotinib—lung cancer	0.0038	0.00546	CcSEcCtD
Droperidol—Rash—Pemetrexed—lung cancer	0.00374	0.00538	CcSEcCtD
Droperidol—Dermatitis—Pemetrexed—lung cancer	0.00374	0.00537	CcSEcCtD
Droperidol—Rash—Gefitinib—lung cancer	0.00372	0.00534	CcSEcCtD
Droperidol—Dermatitis—Gefitinib—lung cancer	0.00372	0.00534	CcSEcCtD
Droperidol—KCNH2—lymph node—lung cancer	0.00368	0.0172	CbGeAlD
Droperidol—Anxiety—Erlotinib—lung cancer	0.00367	0.00527	CcSEcCtD
Droperidol—Bronchospasm—Etoposide—lung cancer	0.00362	0.0052	CcSEcCtD
Droperidol—HTR2A—lung—lung cancer	0.0036	0.0169	CbGeAlD
Droperidol—Anaphylactic shock—Topotecan—lung cancer	0.00357	0.00512	CcSEcCtD
Droperidol—Hypersensitivity—Teniposide—lung cancer	0.00354	0.00509	CcSEcCtD
Droperidol—Haloperidol—CYP1A1—lung cancer	0.00349	0.19	CrCbGaD
Droperidol—Shock—Erlotinib—lung cancer	0.00347	0.00498	CcSEcCtD
Droperidol—Amenorrhoea—Doxorubicin—lung cancer	0.00346	0.00497	CcSEcCtD
Droperidol—Angioedema—Vinorelbine—lung cancer	0.00341	0.0049	CcSEcCtD
Droperidol—Palpitations—Vinorelbine—lung cancer	0.0033	0.00474	CcSEcCtD
Droperidol—Hyperglycaemia—Paclitaxel—lung cancer	0.00325	0.00467	CcSEcCtD
Droperidol—Hypertension—Vinorelbine—lung cancer	0.00323	0.00463	CcSEcCtD
Droperidol—Depression—Paclitaxel—lung cancer	0.00321	0.00461	CcSEcCtD
Droperidol—Chills—Irinotecan—lung cancer	0.00318	0.00456	CcSEcCtD
Droperidol—Gynaecomastia—Methotrexate—lung cancer	0.00314	0.00451	CcSEcCtD
Droperidol—Chills—Gemcitabine—lung cancer	0.00309	0.00444	CcSEcCtD
Droperidol—Anaphylactic shock—Vinorelbine—lung cancer	0.00305	0.00438	CcSEcCtD
Droperidol—Ventricular tachycardia—Doxorubicin—lung cancer	0.00304	0.00437	CcSEcCtD
Droperidol—Rash—Teniposide—lung cancer	0.00303	0.00436	CcSEcCtD
Droperidol—Dermatitis—Teniposide—lung cancer	0.00303	0.00435	CcSEcCtD
Droperidol—Bronchospasm—Docetaxel—lung cancer	0.00301	0.00432	CcSEcCtD
Droperidol—Tachycardia—Vinorelbine—lung cancer	0.00298	0.00427	CcSEcCtD
Droperidol—Hypotension—Vinorelbine—lung cancer	0.00285	0.00409	CcSEcCtD
Droperidol—Body temperature increased—Topotecan—lung cancer	0.00282	0.00405	CcSEcCtD
Droperidol—Body temperature increased—Erlotinib—lung cancer	0.00279	0.004	CcSEcCtD
Droperidol—Syncope—Irinotecan—lung cancer	0.00276	0.00397	CcSEcCtD
Droperidol—Loss of consciousness—Irinotecan—lung cancer	0.00271	0.00389	CcSEcCtD
Droperidol—Hypersensitivity—Vinblastine—lung cancer	0.0027	0.00388	CcSEcCtD
Droperidol—Hypertension—Irinotecan—lung cancer	0.00266	0.00382	CcSEcCtD
Droperidol—Chills—Etoposide—lung cancer	0.00264	0.00379	CcSEcCtD
Droperidol—Hypersensitivity—Topotecan—lung cancer	0.00263	0.00377	CcSEcCtD
Droperidol—Hypertension—Gemcitabine—lung cancer	0.00259	0.00372	CcSEcCtD
Droperidol—Chills—Paclitaxel—lung cancer	0.00259	0.00372	CcSEcCtD
Droperidol—Anaphylactic shock—Irinotecan—lung cancer	0.00252	0.00361	CcSEcCtD
Droperidol—Shock—Irinotecan—lung cancer	0.00247	0.00355	CcSEcCtD
Droperidol—Anaphylactic shock—Gemcitabine—lung cancer	0.00245	0.00352	CcSEcCtD
Droperidol—Domperidone—ABCB1—lung cancer	0.00243	0.132	CrCbGaD
Droperidol—Dizziness—Vinblastine—lung cancer	0.00243	0.00349	CcSEcCtD
Droperidol—Body temperature increased—Vinorelbine—lung cancer	0.00241	0.00346	CcSEcCtD
Droperidol—Anxiety—Cisplatin—lung cancer	0.00237	0.00341	CcSEcCtD
Droperidol—Dizziness—Topotecan—lung cancer	0.00236	0.00339	CcSEcCtD
Droperidol—Hypotension—Irinotecan—lung cancer	0.00235	0.00338	CcSEcCtD
Droperidol—Dizziness—Erlotinib—lung cancer	0.00233	0.00335	CcSEcCtD
Droperidol—Angioedema—Paclitaxel—lung cancer	0.0023	0.0033	CcSEcCtD
Droperidol—Hypotension—Gemcitabine—lung cancer	0.00229	0.00329	CcSEcCtD
Droperidol—Anaphylactic shock—Cisplatin—lung cancer	0.00228	0.00328	CcSEcCtD
Droperidol—Syncope—Paclitaxel—lung cancer	0.00225	0.00324	CcSEcCtD
Droperidol—Loss of consciousness—Etoposide—lung cancer	0.00225	0.00324	CcSEcCtD
Droperidol—Rash—Topotecan—lung cancer	0.00225	0.00323	CcSEcCtD
Droperidol—Hypersensitivity—Vinorelbine—lung cancer	0.00225	0.00323	CcSEcCtD
Droperidol—Dermatitis—Topotecan—lung cancer	0.00225	0.00323	CcSEcCtD
Droperidol—Somnolence—Irinotecan—lung cancer	0.00224	0.00321	CcSEcCtD
Droperidol—Tachycardia—Cisplatin—lung cancer	0.00223	0.0032	CcSEcCtD
Droperidol—Rash—Erlotinib—lung cancer	0.00222	0.00319	CcSEcCtD
Droperidol—Dermatitis—Erlotinib—lung cancer	0.00222	0.00319	CcSEcCtD
Droperidol—Palpitations—Paclitaxel—lung cancer	0.00222	0.00319	CcSEcCtD
Droperidol—Hypertension—Etoposide—lung cancer	0.00221	0.00318	CcSEcCtD
Droperidol—Loss of consciousness—Paclitaxel—lung cancer	0.00221	0.00317	CcSEcCtD
Droperidol—Chills—Docetaxel—lung cancer	0.0022	0.00315	CcSEcCtD
Droperidol—Somnolence—Gemcitabine—lung cancer	0.00218	0.00313	CcSEcCtD
Droperidol—Hypertension—Paclitaxel—lung cancer	0.00217	0.00312	CcSEcCtD
Droperidol—Hypotension—Cisplatin—lung cancer	0.00213	0.00306	CcSEcCtD
Droperidol—Anxiety—Paclitaxel—lung cancer	0.00213	0.00306	CcSEcCtD
Droperidol—Cardiac arrest—Doxorubicin—lung cancer	0.0021	0.00302	CcSEcCtD
Droperidol—Anaphylactic shock—Etoposide—lung cancer	0.00209	0.003	CcSEcCtD
Droperidol—Anaphylactic shock—Paclitaxel—lung cancer	0.00205	0.00295	CcSEcCtD
Droperidol—Tachycardia—Etoposide—lung cancer	0.00204	0.00293	CcSEcCtD
Droperidol—Pimozide—ABCB1—lung cancer	0.00203	0.11	CrCbGaD
Droperidol—Shock—Paclitaxel—lung cancer	0.00202	0.0029	CcSEcCtD
Droperidol—Dizziness—Vinorelbine—lung cancer	0.00202	0.0029	CcSEcCtD
Droperidol—Tachycardia—Paclitaxel—lung cancer	0.002	0.00288	CcSEcCtD
Droperidol—Body temperature increased—Irinotecan—lung cancer	0.00199	0.00286	CcSEcCtD
Droperidol—Drowsiness—Methotrexate—lung cancer	0.00196	0.00282	CcSEcCtD
Droperidol—Depression—Methotrexate—lung cancer	0.00196	0.00281	CcSEcCtD
Droperidol—Hypotension—Etoposide—lung cancer	0.00195	0.00281	CcSEcCtD
Droperidol—Body temperature increased—Gemcitabine—lung cancer	0.00194	0.00278	CcSEcCtD
Droperidol—Rash—Vinorelbine—lung cancer	0.00192	0.00276	CcSEcCtD
Droperidol—Dermatitis—Vinorelbine—lung cancer	0.00192	0.00276	CcSEcCtD
Droperidol—Hypotension—Paclitaxel—lung cancer	0.00192	0.00275	CcSEcCtD
Droperidol—Syncope—Docetaxel—lung cancer	0.00191	0.00274	CcSEcCtD
Droperidol—Palpitations—Docetaxel—lung cancer	0.00188	0.0027	CcSEcCtD
Droperidol—Loss of consciousness—Docetaxel—lung cancer	0.00187	0.00269	CcSEcCtD
Droperidol—Somnolence—Etoposide—lung cancer	0.00186	0.00267	CcSEcCtD
Droperidol—Hypersensitivity—Irinotecan—lung cancer	0.00185	0.00266	CcSEcCtD
Droperidol—Haloperidol—ABCB1—lung cancer	0.00185	0.101	CrCbGaD
Droperidol—Hypertension—Docetaxel—lung cancer	0.00184	0.00264	CcSEcCtD
Droperidol—Somnolence—Paclitaxel—lung cancer	0.00182	0.00262	CcSEcCtD
Droperidol—Body temperature increased—Cisplatin—lung cancer	0.00181	0.00259	CcSEcCtD
Droperidol—Anaphylactic shock—Docetaxel—lung cancer	0.00174	0.0025	CcSEcCtD
Droperidol—Hyperglycaemia—Doxorubicin—lung cancer	0.00172	0.00247	CcSEcCtD
Droperidol—Shock—Docetaxel—lung cancer	0.00171	0.00246	CcSEcCtD
Droperidol—Drowsiness—Doxorubicin—lung cancer	0.0017	0.00244	CcSEcCtD
Droperidol—Tachycardia—Docetaxel—lung cancer	0.0017	0.00244	CcSEcCtD
Droperidol—Hypersensitivity—Cisplatin—lung cancer	0.00168	0.00242	CcSEcCtD
Droperidol—Dizziness—Irinotecan—lung cancer	0.00166	0.00239	CcSEcCtD
Droperidol—Body temperature increased—Etoposide—lung cancer	0.00165	0.00238	CcSEcCtD
Droperidol—Hypotension—Docetaxel—lung cancer	0.00162	0.00233	CcSEcCtD
Droperidol—Body temperature increased—Paclitaxel—lung cancer	0.00162	0.00233	CcSEcCtD
Droperidol—Rash—Irinotecan—lung cancer	0.00159	0.00228	CcSEcCtD
Droperidol—Dermatitis—Irinotecan—lung cancer	0.00158	0.00228	CcSEcCtD
Droperidol—Chills—Methotrexate—lung cancer	0.00158	0.00227	CcSEcCtD
Droperidol—Somnolence—Docetaxel—lung cancer	0.00155	0.00222	CcSEcCtD
Droperidol—Rash—Gemcitabine—lung cancer	0.00154	0.00222	CcSEcCtD
Droperidol—Dermatitis—Gemcitabine—lung cancer	0.00154	0.00222	CcSEcCtD
Droperidol—Hypersensitivity—Etoposide—lung cancer	0.00154	0.00221	CcSEcCtD
Droperidol—Hypersensitivity—Paclitaxel—lung cancer	0.00151	0.00217	CcSEcCtD
Droperidol—Rash—Cisplatin—lung cancer	0.00144	0.00207	CcSEcCtD
Droperidol—Dermatitis—Cisplatin—lung cancer	0.00144	0.00207	CcSEcCtD
Droperidol—Dizziness—Etoposide—lung cancer	0.00138	0.00199	CcSEcCtD
Droperidol—Body temperature increased—Docetaxel—lung cancer	0.00137	0.00197	CcSEcCtD
Droperidol—Chills—Doxorubicin—lung cancer	0.00137	0.00197	CcSEcCtD
Droperidol—Dizziness—Paclitaxel—lung cancer	0.00136	0.00195	CcSEcCtD
Droperidol—Rash—Etoposide—lung cancer	0.00132	0.00189	CcSEcCtD
Droperidol—Dermatitis—Etoposide—lung cancer	0.00132	0.00189	CcSEcCtD
Droperidol—Rash—Paclitaxel—lung cancer	0.00129	0.00186	CcSEcCtD
Droperidol—Dermatitis—Paclitaxel—lung cancer	0.00129	0.00186	CcSEcCtD
Droperidol—Hypersensitivity—Docetaxel—lung cancer	0.00128	0.00184	CcSEcCtD
Droperidol—Anaphylactic shock—Methotrexate—lung cancer	0.00125	0.0018	CcSEcCtD
Droperidol—Syncope—Doxorubicin—lung cancer	0.00119	0.00171	CcSEcCtD
Droperidol—Palpitations—Doxorubicin—lung cancer	0.00117	0.00169	CcSEcCtD
Droperidol—Hypotension—Methotrexate—lung cancer	0.00117	0.00168	CcSEcCtD
Droperidol—Loss of consciousness—Doxorubicin—lung cancer	0.00117	0.00168	CcSEcCtD
Droperidol—Dizziness—Docetaxel—lung cancer	0.00115	0.00165	CcSEcCtD
Droperidol—Hypertension—Doxorubicin—lung cancer	0.00115	0.00165	CcSEcCtD
Droperidol—Anxiety—Doxorubicin—lung cancer	0.00113	0.00162	CcSEcCtD
Droperidol—Somnolence—Methotrexate—lung cancer	0.00111	0.0016	CcSEcCtD
Droperidol—Rash—Docetaxel—lung cancer	0.0011	0.00157	CcSEcCtD
Droperidol—Dermatitis—Docetaxel—lung cancer	0.0011	0.00157	CcSEcCtD
Droperidol—Anaphylactic shock—Doxorubicin—lung cancer	0.00109	0.00156	CcSEcCtD
Droperidol—Shock—Doxorubicin—lung cancer	0.00107	0.00153	CcSEcCtD
Droperidol—Tachycardia—Doxorubicin—lung cancer	0.00106	0.00152	CcSEcCtD
Droperidol—Hypotension—Doxorubicin—lung cancer	0.00101	0.00146	CcSEcCtD
Droperidol—Body temperature increased—Methotrexate—lung cancer	0.000991	0.00142	CcSEcCtD
Droperidol—Somnolence—Doxorubicin—lung cancer	0.000965	0.00139	CcSEcCtD
Droperidol—Hypersensitivity—Methotrexate—lung cancer	0.000923	0.00133	CcSEcCtD
Droperidol—Body temperature increased—Doxorubicin—lung cancer	0.000858	0.00123	CcSEcCtD
Droperidol—Dizziness—Methotrexate—lung cancer	0.000829	0.00119	CcSEcCtD
Droperidol—Hypersensitivity—Doxorubicin—lung cancer	0.000799	0.00115	CcSEcCtD
Droperidol—Rash—Methotrexate—lung cancer	0.00079	0.00113	CcSEcCtD
Droperidol—Dermatitis—Methotrexate—lung cancer	0.000789	0.00113	CcSEcCtD
Droperidol—Dizziness—Doxorubicin—lung cancer	0.000718	0.00103	CcSEcCtD
Droperidol—Rash—Doxorubicin—lung cancer	0.000684	0.000983	CcSEcCtD
Droperidol—Dermatitis—Doxorubicin—lung cancer	0.000684	0.000982	CcSEcCtD
Droperidol—DRD2—Signaling Pathways—PPP2R1B—lung cancer	4.66e-05	0.000649	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—SMARCA4—lung cancer	4.66e-05	0.000649	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ADCY1—lung cancer	4.61e-05	0.000642	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PPP2R1B—lung cancer	4.58e-05	0.000639	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—SMARCA4—lung cancer	4.58e-05	0.000639	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—HSPB1—lung cancer	4.5e-05	0.000626	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PPP2R1B—lung cancer	4.49e-05	0.000625	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—SMARCA4—lung cancer	4.49e-05	0.000625	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PTHLH—lung cancer	4.44e-05	0.000619	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—HSPB1—lung cancer	4.42e-05	0.000616	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PTHLH—lung cancer	4.37e-05	0.000609	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—HSPB1—lung cancer	4.33e-05	0.000603	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PTHLH—lung cancer	4.28e-05	0.000597	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—ANXA1—lung cancer	4.18e-05	0.000582	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ANXA1—lung cancer	4.11e-05	0.000573	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—FLT1—lung cancer	4.05e-05	0.000564	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ANXA1—lung cancer	4.03e-05	0.000561	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—PIK3CG—lung cancer	4.01e-05	0.000559	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—FLT1—lung cancer	3.98e-05	0.000555	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—APP—lung cancer	3.96e-05	0.000552	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—NOTCH3—lung cancer	3.96e-05	0.000552	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—PIK3CG—lung cancer	3.95e-05	0.00055	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—FGF9—lung cancer	3.93e-05	0.000547	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—FLT1—lung cancer	3.9e-05	0.000543	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—APP—lung cancer	3.9e-05	0.000543	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—NOTCH3—lung cancer	3.9e-05	0.000543	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—FGF9—lung cancer	3.87e-05	0.000539	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—PIK3CG—lung cancer	3.86e-05	0.000538	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—APP—lung cancer	3.82e-05	0.000532	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—NOTCH3—lung cancer	3.82e-05	0.000532	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—POMC—lung cancer	3.82e-05	0.000532	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—FGF9—lung cancer	3.79e-05	0.000527	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—POMC—lung cancer	3.76e-05	0.000523	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—JUNB—lung cancer	3.75e-05	0.000523	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—JUNB—lung cancer	3.69e-05	0.000514	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—POMC—lung cancer	3.68e-05	0.000512	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—PIK3CG—lung cancer	3.64e-05	0.000507	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—JUNB—lung cancer	3.61e-05	0.000504	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—PIK3CG—lung cancer	3.58e-05	0.000499	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—PIK3CD—lung cancer	3.52e-05	0.000491	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—PIK3CG—lung cancer	3.51e-05	0.000489	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—PIK3CD—lung cancer	3.47e-05	0.000483	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—POMC—lung cancer	3.47e-05	0.000483	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—POMC—lung cancer	3.41e-05	0.000475	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—STK11—lung cancer	3.41e-05	0.000475	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—PIK3CD—lung cancer	3.4e-05	0.000473	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—IL6R—lung cancer	3.38e-05	0.000471	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—STK11—lung cancer	3.35e-05	0.000467	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—POMC—lung cancer	3.34e-05	0.000465	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—IL6R—lung cancer	3.33e-05	0.000463	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—FOXO3—lung cancer	3.29e-05	0.000458	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—STK11—lung cancer	3.28e-05	0.000457	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—IL6R—lung cancer	3.26e-05	0.000454	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—FOXO3—lung cancer	3.24e-05	0.000451	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—MAP2K1—lung cancer	3.22e-05	0.000449	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—PIK3CD—lung cancer	3.2e-05	0.000446	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—MAP2K1—lung cancer	3.17e-05	0.000442	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—FOXO3—lung cancer	3.17e-05	0.000441	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—PIK3CD—lung cancer	3.15e-05	0.000439	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—MAP2K1—lung cancer	3.1e-05	0.000432	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—PIK3CD—lung cancer	3.08e-05	0.00043	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—AVP—lung cancer	3.08e-05	0.000429	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—PIK3CB—lung cancer	3.07e-05	0.000428	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—AVP—lung cancer	3.03e-05	0.000422	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—PIK3CB—lung cancer	3.02e-05	0.000421	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—AVP—lung cancer	2.97e-05	0.000414	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IGF1R—lung cancer	2.97e-05	0.000413	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—PIK3CB—lung cancer	2.96e-05	0.000412	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—CXCL8—lung cancer	2.95e-05	0.000411	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IGF1R—lung cancer	2.92e-05	0.000407	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—HES1—lung cancer	2.91e-05	0.000406	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—CXCL8—lung cancer	2.9e-05	0.000405	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—HES1—lung cancer	2.87e-05	0.000399	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—RAF1—lung cancer	2.86e-05	0.000398	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IGF1R—lung cancer	2.86e-05	0.000398	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—CXCL8—lung cancer	2.84e-05	0.000396	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—IL2—lung cancer	2.82e-05	0.000393	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—RAF1—lung cancer	2.81e-05	0.000392	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—HES1—lung cancer	2.81e-05	0.000391	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—PIK3CB—lung cancer	2.79e-05	0.000389	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—IL2—lung cancer	2.78e-05	0.000387	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—RAF1—lung cancer	2.75e-05	0.000384	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—PIK3CB—lung cancer	2.75e-05	0.000382	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—IL2—lung cancer	2.72e-05	0.000379	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—PIK3CB—lung cancer	2.69e-05	0.000374	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—CXCL8—lung cancer	2.68e-05	0.000374	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—ERBB3—lung cancer	2.66e-05	0.000371	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—CXCL8—lung cancer	2.64e-05	0.000368	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ERBB3—lung cancer	2.62e-05	0.000365	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—CXCL8—lung cancer	2.58e-05	0.00036	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ERBB3—lung cancer	2.57e-05	0.000358	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—IL2—lung cancer	2.56e-05	0.000357	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—TERT—lung cancer	2.55e-05	0.000356	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—IL2—lung cancer	2.52e-05	0.000351	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—TERT—lung cancer	2.51e-05	0.00035	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—FGFR1—lung cancer	2.48e-05	0.000345	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—IL2—lung cancer	2.47e-05	0.000344	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—TERT—lung cancer	2.46e-05	0.000343	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—HIF1A—lung cancer	2.44e-05	0.00034	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—FGFR1—lung cancer	2.44e-05	0.00034	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—HIF1A—lung cancer	2.4e-05	0.000335	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—FGFR1—lung cancer	2.39e-05	0.000333	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—APOA1—lung cancer	2.36e-05	0.000328	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—HIF1A—lung cancer	2.35e-05	0.000328	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—KDR—lung cancer	2.33e-05	0.000325	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—APOA1—lung cancer	2.32e-05	0.000323	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—KDR—lung cancer	2.3e-05	0.00032	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—APOA1—lung cancer	2.27e-05	0.000316	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—KDR—lung cancer	2.25e-05	0.000313	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—APC—lung cancer	2.15e-05	0.0003	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—KIT—lung cancer	2.15e-05	0.0003	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PIK3CG—lung cancer	2.15e-05	0.0003	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—NRAS—lung cancer	2.15e-05	0.0003	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—EGF—lung cancer	2.13e-05	0.000296	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PIK3CG—lung cancer	2.12e-05	0.000295	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—APC—lung cancer	2.12e-05	0.000295	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—KIT—lung cancer	2.12e-05	0.000295	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—NRAS—lung cancer	2.12e-05	0.000295	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—EGF—lung cancer	2.09e-05	0.000291	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PIK3CG—lung cancer	2.07e-05	0.000289	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—APC—lung cancer	2.07e-05	0.000289	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—KIT—lung cancer	2.07e-05	0.000289	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—NRAS—lung cancer	2.07e-05	0.000289	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—MAPK3—lung cancer	2.06e-05	0.000287	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—EGF—lung cancer	2.05e-05	0.000285	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—POMC—lung cancer	2.05e-05	0.000285	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—MAPK3—lung cancer	2.03e-05	0.000282	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—BRAF—lung cancer	2.02e-05	0.000282	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—POMC—lung cancer	2.01e-05	0.000281	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IL6R—lung cancer	2e-05	0.000278	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CREBBP—lung cancer	1.99e-05	0.000278	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—BRAF—lung cancer	1.99e-05	0.000277	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—MAPK3—lung cancer	1.98e-05	0.000276	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—POMC—lung cancer	1.97e-05	0.000275	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IL6R—lung cancer	1.97e-05	0.000274	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CREBBP—lung cancer	1.96e-05	0.000273	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—EGFR—lung cancer	1.96e-05	0.000273	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—BRAF—lung cancer	1.95e-05	0.000271	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—EGFR—lung cancer	1.93e-05	0.000269	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IL6R—lung cancer	1.92e-05	0.000268	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CREBBP—lung cancer	1.92e-05	0.000268	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MAP2K1—lung cancer	1.9e-05	0.000265	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PIK3CD—lung cancer	1.89e-05	0.000263	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—EGFR—lung cancer	1.89e-05	0.000263	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—PIK3CA—lung cancer	1.87e-05	0.000261	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MAP2K1—lung cancer	1.87e-05	0.000261	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PIK3CD—lung cancer	1.86e-05	0.000259	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—KRAS—lung cancer	1.85e-05	0.000258	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—PIK3CA—lung cancer	1.84e-05	0.000257	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MAP2K1—lung cancer	1.83e-05	0.000255	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PIK3CD—lung cancer	1.82e-05	0.000254	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—KRAS—lung cancer	1.82e-05	0.000254	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—PIK3CA—lung cancer	1.8e-05	0.000251	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—KRAS—lung cancer	1.78e-05	0.000248	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—PIK3CA—lung cancer	1.7e-05	0.000237	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MDM2—lung cancer	1.69e-05	0.000236	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—RAF1—lung cancer	1.69e-05	0.000235	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—PIK3CA—lung cancer	1.67e-05	0.000233	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—ERBB2—lung cancer	1.67e-05	0.000233	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MDM2—lung cancer	1.67e-05	0.000232	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—RAF1—lung cancer	1.66e-05	0.000231	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MTOR—lung cancer	1.65e-05	0.00023	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PIK3CB—lung cancer	1.65e-05	0.00023	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ERBB2—lung cancer	1.64e-05	0.000229	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—PIK3CA—lung cancer	1.64e-05	0.000228	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MDM2—lung cancer	1.63e-05	0.000227	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—RAF1—lung cancer	1.63e-05	0.000227	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MTOR—lung cancer	1.62e-05	0.000226	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PIK3CB—lung cancer	1.62e-05	0.000226	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ERBB2—lung cancer	1.61e-05	0.000224	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MTOR—lung cancer	1.59e-05	0.000221	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PIK3CB—lung cancer	1.59e-05	0.000221	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CXCL8—lung cancer	1.58e-05	0.000221	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—HRAS—lung cancer	1.57e-05	0.000219	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CXCL8—lung cancer	1.56e-05	0.000217	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—HRAS—lung cancer	1.55e-05	0.000216	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—AKT1—lung cancer	1.53e-05	0.000213	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CXCL8—lung cancer	1.53e-05	0.000213	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—HRAS—lung cancer	1.52e-05	0.000211	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CASP3—lung cancer	1.52e-05	0.000211	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IL2—lung cancer	1.51e-05	0.000211	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—IL6—lung cancer	1.51e-05	0.00021	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—AKT1—lung cancer	1.51e-05	0.00021	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CASP3—lung cancer	1.49e-05	0.000208	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IL2—lung cancer	1.49e-05	0.000207	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—IL6—lung cancer	1.48e-05	0.000206	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CCND1—lung cancer	1.48e-05	0.000206	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—AKT1—lung cancer	1.47e-05	0.000205	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—JUN—lung cancer	1.47e-05	0.000205	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CASP3—lung cancer	1.46e-05	0.000203	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IL2—lung cancer	1.46e-05	0.000203	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CCND1—lung cancer	1.45e-05	0.000202	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—IL6—lung cancer	1.45e-05	0.000202	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—JUN—lung cancer	1.45e-05	0.000202	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MMP9—lung cancer	1.43e-05	0.0002	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CDKN1A—lung cancer	1.43e-05	0.000199	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PTEN—lung cancer	1.42e-05	0.000198	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CCND1—lung cancer	1.42e-05	0.000198	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—JUN—lung cancer	1.42e-05	0.000198	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MMP9—lung cancer	1.41e-05	0.000196	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CDKN1A—lung cancer	1.4e-05	0.000196	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PTEN—lung cancer	1.4e-05	0.000195	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—AKT1—lung cancer	1.39e-05	0.000194	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MMP9—lung cancer	1.38e-05	0.000192	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CDKN1A—lung cancer	1.38e-05	0.000192	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PTEN—lung cancer	1.37e-05	0.000191	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—AKT1—lung cancer	1.37e-05	0.00019	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—EP300—lung cancer	1.36e-05	0.000189	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—AKT1—lung cancer	1.34e-05	0.000186	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—EP300—lung cancer	1.34e-05	0.000186	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—SRC—lung cancer	1.32e-05	0.000184	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—EP300—lung cancer	1.31e-05	0.000182	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—SRC—lung cancer	1.3e-05	0.000181	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—VEGFA—lung cancer	1.29e-05	0.000179	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—STAT3—lung cancer	1.27e-05	0.000177	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—SRC—lung cancer	1.27e-05	0.000177	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—NRAS—lung cancer	1.27e-05	0.000177	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—VEGFA—lung cancer	1.27e-05	0.000176	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—STAT3—lung cancer	1.25e-05	0.000175	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—NRAS—lung cancer	1.25e-05	0.000174	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—VEGFA—lung cancer	1.24e-05	0.000173	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—STAT3—lung cancer	1.23e-05	0.000171	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—NRAS—lung cancer	1.22e-05	0.000171	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MAPK3—lung cancer	1.22e-05	0.00017	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MAPK3—lung cancer	1.2e-05	0.000167	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MYC—lung cancer	1.18e-05	0.000165	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MAPK3—lung cancer	1.17e-05	0.000163	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MYC—lung cancer	1.16e-05	0.000162	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—EGFR—lung cancer	1.16e-05	0.000161	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MYC—lung cancer	1.14e-05	0.000159	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—EGFR—lung cancer	1.14e-05	0.000159	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—EGFR—lung cancer	1.12e-05	0.000155	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—KRAS—lung cancer	1.09e-05	0.000152	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—KRAS—lung cancer	1.08e-05	0.00015	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—KRAS—lung cancer	1.05e-05	0.000147	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PIK3CA—lung cancer	1e-05	0.00014	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PIK3CA—lung cancer	9.89e-06	0.000138	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—TP53—lung cancer	9.72e-06	0.000135	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PIK3CA—lung cancer	9.68e-06	0.000135	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—TP53—lung cancer	9.56e-06	0.000133	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—TP53—lung cancer	9.36e-06	0.00013	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—HRAS—lung cancer	9.3e-06	0.00013	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—HRAS—lung cancer	9.15e-06	0.000127	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—HRAS—lung cancer	8.96e-06	0.000125	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IL6—lung cancer	8.9e-06	0.000124	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IL6—lung cancer	8.75e-06	0.000122	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IL6—lung cancer	8.57e-06	0.000119	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—AKT1—lung cancer	8.21e-06	0.000114	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—AKT1—lung cancer	8.08e-06	0.000113	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—AKT1—lung cancer	7.91e-06	0.00011	CbGpPWpGaD
